Back to Search
DAVID MCKINNEY, MD
MD
Occupational Medicine Physician
NPI: 1285953067Individual
Specialties, Licenses & Credentials
Independent Medical Examiner Physician
Independent Medical Examiner
Code: 202C00000X
G54844(CA)
Occupational Medicine PhysicianPrimary
Preventive Medicine — Occupational Medicine
Code: 2083X0100X
G54844(CA)
Research & Publications (20)
Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site.
PMID 17554032·J Gen Virol·2007
8-other
Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
PMID 15265928·J Immunol·2004
4-observational
Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs.
PMID 11035079·J Immunol·2000
4-observational
Characterization of an in situ IFN-gamma ELISA assay which is able to detect specific peptide responses from freshly isolated splenocytes induced by DNA minigene immunization.
PMID 10725456·J Immunol Methods·2000
4-observational
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.
PMID 19262754·PLoS One·2009
3-trial
Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
PMID 17967938·J Pharmacol Exp Ther·2008
4-observational
Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
PMID 17942551·J Virol·2008
7-preclinical
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.
PMID 17574311·Vaccine·2007
3-trial
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
PMID 16388879·Vaccine·2007
3-trial
Gender differences in adhering to national guidelines in a community lipid clinic.
PMID 17085984·Prev Cardiol·2006
4-observational
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.
PMID 17124529·PLoS Clin Trials·2006
8-other
Synthesis of amine- and thiol-modified nucleoside phosphoramidites for site-specific introduction of biophysical probes into RNA.
PMID 15903302·J Org Chem·2005
8-other
Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
PMID 16175596·Hepatology·2005
8-other
Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
PMID 14607970·J Immunol·2003
3-trial
Effectiveness of statin-gemfibrozil combination therapy in patients with mixed hyperlipidemia: experience of a community lipid clinic and safety review from the literature.
PMID 14605512·Prev Cardiol·2003
8-other
Bivalirudin in peripheral vascular interventions: a single center experience.
PMID 12840239·J Invasive Cardiol·2003
3-trial
In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant.
PMID 12730630·J Invasive Cardiol·2003
4-observational
Optimizing vaccine design for cellular processing, MHC binding and TCR recognition.
PMID 12445314·Tissue Antigens·2002
6-review
Oliguric acute renal failure in mycosis fungoides with lymphomatous infiltrates in the kidneys.
PMID 12090323·Int Urol Nephrol·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1940 FEATHER RIVER BLVD, SUITE #O
OROVILLE, CA 95965 - Phone
- (530) 534-5135
Quick Facts
- NPI
- 1285953067
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile